Login / Signup

A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder.

Kelly C AllisonAriana M ChaoMaija B BruzasCourtney McCuen-WurstElizabeth JonesCooper McAllisterKathryn GruberRobert I BerkowitzThomas A WaddenJena S Tronieri
Published in: Obesity science & practice (2022)
Participants in both groups reported reductions in OBEs, with the liraglutide group showing clinically meaningful weight loss. A pharmacy medication dispensing error was a significant limitation of this study. Further research on liraglutide and other GLP-1 agonists for BED is warranted.
Keyphrases
  • weight loss
  • healthcare
  • bariatric surgery
  • study protocol
  • clinical trial
  • emergency department
  • roux en y gastric bypass
  • metabolic syndrome
  • insulin resistance
  • adverse drug
  • skeletal muscle
  • double blind